Interaction of human gut microbiota and local immune system in progression of colorectal adenoma (MIMICA-1): a protocol for a prospective, observational cohort study.

Journal: Frontiers in oncology
Published Date:

Abstract

INTRODUCTION: The current understanding of colorectal carcinogenesis is based on the adenoma-carcinoma sequence, where genetics, intestinal microbiota changes and local immunity shifts seem to play the key roles. Despite the emerging evidence of dysbiotic intestinal state and immune-cell infiltration changes in patients with colorectal adenocarcinoma, early and advanced adenoma as precursors of colorectal cancer, and carcinoma as the following progression, are rather less studied. The newly colon-site adapted AI-based analysis of immune infiltrates is able to predict long-term outcomes of colon carcinoma. Though it could also facilitate the pathologic evaluation of precancerous lesion's potential to progress. Therefore, the purpose of this prospective cohort study (MIMICA-1) is, firstly, to identify the intestinal microbiota and immune infiltration patterns around the normal bowel tissue, early and advanced adenoma, carcinoma in situ, and adenocarcinoma, and secondly, to analyze the immune - microbiome interplay along the steps of conventional colorectal tumorigenesis.

Authors

  • Jurate Valciukiene
    Clinic of Gastroenterology, Nephro-Urology, and Surgery, Institute of Clinical Medicine, Faculty of Medicine, Vilnius University, Vilnius, Lithuania.
  • Egle Lastauskiene
    Institute of Biosciences, Life Sciences Center, Vilnius University, Vilnius, Lithuania.
  • Aida Laurinaviciene
    National Center of Pathology, Vilnius University Hospital Santaros Klinikos, Vilnius, Lithuania.
  • Matas Jakubauskas
    Clinic of Gastroenterology, Nephro-Urology, and Surgery, Institute of Clinical Medicine, Faculty of Medicine, Vilnius University, Vilnius, Lithuania.
  • Marius Kryzauskas
    Clinic of Gastroenterology, Nephro-Urology, and Surgery, Institute of Clinical Medicine, Faculty of Medicine, Vilnius University, Vilnius, Lithuania.
  • Ruta Barbora Valkiuniene
    National Center of Pathology, Vilnius University Hospital Santaros Klinikos, Vilnius, Lithuania.
  • Renaldas Augulis
    National Center of Pathology, Vilnius University Hospital Santaros Klinikos, Vilnius, Lithuania.
  • Ausra Garnelyte
    National Center of Pathology, Vilnius University Hospital Santaros Klinikos, Vilnius, Lithuania.
  • Justinas Kavoliunas
    Institute of Biosciences, Life Sciences Center, Vilnius University, Vilnius, Lithuania.
  • Ugne Silinskaite
    Faculty of Medicine, Vilnius University, Vilnius, Lithuania.
  • Tomas Poskus
    Clinic of Gastroenterology, Nephro-Urology, and Surgery, Institute of Clinical Medicine, Faculty of Medicine, Vilnius University, Vilnius, Lithuania.

Keywords

No keywords available for this article.